Quick Answer
Armata Pharmaceuticals, Inc. reported Total Assets of $76.88 million for fiscal year 2025.
Armata Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $76.88M | -11.1% |
| 2024 | $86.44M | -12.1% |
| 2023 | $98.36M | +2.6% |
| 2022 | $95.83M | +37.4% |
| 2021 | $69.77M | +76.6% |
| 2020 | $39.52M | +55.3% |
| 2019 | $25.45M | +75.0% |
| 2018 | $14.54M | +30.6% |
| 2017 | $11.14M | -38.6% |
| 2016 | $18.15M | -42.4% |
| 2015 | $31.49M | +10.0% |
| 2014 | $28.62M | -30.6% |
| 2013 | $41.21M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $89.52M | -8.9% | +10.8% |
| June 30, 2025 | $80.79M | -25.4% | -7.4% |
| March 31, 2025 | $87.25M | -27.5% | +0.9% |
| December 31, 2024 | $86.44M | -12.1% | -12.0% |
| September 30, 2024 | $98.24M | -12.9% | -9.3% |
| June 30, 2024 | $108.31M | +7.0% | -10.0% |
| March 31, 2024 | $120.36M | +10.6% | +22.4% |
| December 31, 2023 | $98.36M | +2.6% | -12.8% |
- Armata Pharmaceuticals, Inc. showed a decrease of -11.1% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Armata Pharmaceuticals, Inc.’s total assets has grown by 86.5% (from $41.21 million to $76.88 million).
- The most recent figure is from Armata Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: